APP and Alzheimer disease: Indeed, not only Nrf2 was described to be predominantly cytoplasmatic in hippocampal neurons from AD patients, resulting in decreased nuclear levels [221], but also Nrf2-ARE pathway was shown to be attenuated in APP/PS1 transgenic mouse brain at the time of Aβ deposition [222].